Fox Chase Cancer Center News

PHILADELPHIA (September 20, 2019) – Many of the most common treatment modalities for localized non-melanoma skin cancers resulted in similar cosmetic outcome and local control one year after treatment, according to a new study from researchers at Fox Chase Cancer Center.

CHICAGO (September 15, 2019) – New research from Fox Chase Cancer Center may help guide men with prostate cancer in selecting the appropriate type of short course radiation therapy to treat their disease.

CHICAGO (September 15, 2019) – Patients with esophageal cancer who experienced severe lymphopenia after undergoing chemoradiation were more likely to have their disease recur and were at greater risk for death, according to a new study from researchers at Fox Chase Cancer Center.

PHILADELPHIA (September 13, 2019) – Fox Chase Cancer Center hired Michael Jay Styler, MD, for the Department of Hematology/Oncology as an associate professor in the Bone Marrow Transplant Program.

PHILADELPHIA (September 11, 2019) – Denise Connolly, PhD, an associate professor in the Molecular Therapeutics Program, has won the Sandy Rollman Ovarian Cancer Foundation’s Teal Trailblazer Award. She is currently researching high-grade serous carcinoma to understand why not all ovarian cancer arises in the ovary.

PHILADELPHIA (September 11, 2019) – Anne Jadwin, MSN, RN, AOCN, NE-BC, Vice President of Nursing Services and Chief Nursing Officer, was honored with the 2019 Distinguished Alumni Award from Gwynedd Mercy University. The award recognizes the achievements of outstanding alumni whose “personal lives, professional achievements, and community service exemplify the objectives of their alma mater.”

PHILADELPHIA (September 10, 2019) – Marcin Chwistek, MD, FAAHPM, director of the Pain and Palliative Care Program, has been appointed Editor-in-Chief of AAHPM Quarterly.

PHILADELPHIA (September 9, 2019) – Andrew J. Andrews, PhD, has been awarded a $33,348 grant from the National Cancer Institute for research attempting to determine the fundamental processes by which cancer cells can sense deficiencies in the production of essential metabolic components and adapt to overcome this and survive.